Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Non-Current Assets: 2011-2017

Historic Non-Current Assets for Tenax Therapeutics (TENX) over the last 4 years, with Sep 2017 value amounting to $2.3 million.

  • Tenax Therapeutics' Non-Current Assets fell 95.50% to $2.3 million in Q3 2017 from the same period last year, while for Sep 2017 it was $2.3 million, marking a year-over-year decrease of 95.50%. This contributed to the annual value of $9.7 million for FY2016, which is N/A change from last year.
  • According to the latest figures from Q3 2017, Tenax Therapeutics' Non-Current Assets is $2.3 million, which was down 47.44% from $4.5 million recorded in Q2 2017.
  • Tenax Therapeutics' Non-Current Assets' 5-year high stood at $54.0 million during Q2 2016, with a 5-year trough of $1.3 million in Q2 2013.
  • Over the past 3 years, Tenax Therapeutics' median Non-Current Assets value was $9.7 million (recorded in 2016), while the average stood at $25.9 million.
  • Data for Tenax Therapeutics' Non-Current Assets shows a maximum YoY crashed of 95.50% (in 2017) over the last 5 years.
  • Quarterly analysis of 4 years shows Tenax Therapeutics' Non-Current Assets stood at $1.3 million in 2013, then reached $52.4 million in 2015, then plummeted by 81.48% to $9.7 million in 2016, then slumped by 95.50% to $2.3 million in 2017.
  • Its Non-Current Assets stands at $2.3 million for Q3 2017, versus $4.5 million for Q2 2017 and $6.4 million for Q1 2017.